India Daybook – Stocks in News

*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY 

*TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 cr, Revenue at Rs 8144.0 cr vs poll Rs 8184.0 cr YoY 

*DCX System:* Net profit up 49% at Rs 20.0 cr, Revenue up 78% at Rs 309.0 cr YoY 

*Vesuvius:* Net profit at Rs 60 cr vs Rs 36.0 cr, Revenue up at Rs 413.0 cr vs Rs 352.0 cr YoY 

 *Vaibhav Global:* Net profit at Rs 29.4 cr vs Rs 22.9 cr, Revenue up at Rs 700.0 cr vs Rs 646.0 cr YoY 

*De Nora:* Net profit at Rs 6.4 cr vs Rs 1.6 cr, Revenue up at Rs 19.1 cr vs Rs 14.4 cr YoY 

*Nelcast:* Net profit at Rs 16.6 cr vs Rs 12.1 cr, Revenue up at Rs 358.0 cr vs Rs 329.0 cr YoY 

*Mangalore Chem:* Net profit at Rs 67.0 cr vs loss Rs 32.2 cr, Revenue up at Rs 141.0 cr vs Rs 283.0 cr YoY 

*SIS:* Net profit at Rs 75.3 cr vs Rs 67.4 cr, Revenue up at Rs 3074.0 cr vs Rs 2768.0 cr YoY 

*Spandana:* Net profit at Rs 116 cr vs Rs 49.5 cr, Revenue at Rs 584.0 cr vs Rs 281.0 cr YoY 

*Tata Motors:* Arbitral tribunal rules in favour of company and Tribunal asked West Bengal Industrial Development to pay Tata Motors Rs 766 cr + interest at 11% 

*Chemplast Sanmar:* Company's chemicals division gets LoI to manufacture pipeline Active Ingredient. 

*Bajaj Hindusthan:* Company gets Rs 1,361 crore order toward cane payment arrears from Uttar Pradesh Power Corp 

*Triveni Eng:* Net profit down 97.9% at Rs 29.1 cr vs Rs 1,388 cr, Revenue up 9.9% at Rs 1,617.4 cr vs Rs 1,471.6 cr (YoY) 

 *GMR Airports:* Net loss of Rs 190.4 cr vs loss of Rs 197.1 cr, Revenue up 30.3% at Rs 2,063.5 cr vs Rs 1,583.6 cr YoY 

*Castrol:* Net profit up 3.8 at Rs 194.4 cr Vs Rs 187.2 cr, Revenue up 5.5% at Rs 1,183 cr Vs Rs 1,121 cr (YoY) *Sterling Tools:* Net profit down 24.7% at Rs 12.5 Cr vs Rs 17 cr, Revenue up 17.7% at Rs 210.2 Cr Vs Rs 178.6 cr (YoY) 

*DLF:* Net profit up 30.6% at Rs 622.8 cr vs Rs 477 cr, Revenue up 3.5% At Rs 1,347.7 Cr Vs Rs 1,302.3 cr (YoY) 

*APL Apollo:* Net profit up 35% at Rs 203.0 cr, Revenue up 17% at Rs 4630.0 cr YoY 

*LG Balakrishnan:* Net profit up 12.4% at Rs 75.5 cr vs Rs 67 cr, Revenue up 3.8% at Rs 600 cr vs Rs 578 cr (YoY) 

*Rainbow:* Net profit at Rs 62.9 cr vs Rs 61.1 cr, Revenue at Rs 333 cr vs Rs 313 cr YoY 

*Marico:* Net profit at Rs 360.0 cr vs poll Rs 346.0 cr, Revenue at Rs 2476.0 cr vs poll Rs 2464.0 cr YoY 

*DCM Shriram:* Company to set up sugar plant at Loni, Uttar Pradesh. 

*Colgate:* Company gets Transfer Pricing Order from the Income Tax Authority for AY22; income Tax liability of Rs 170 Cr 

 *DCM Shriram:* Net profit down 75% at Rs 32.0 cr, Revenue down 2% at Rs 2708.0 cr YoY 

*Fine Organics:* Net profit down 49% at Rs 103.0 cr, Revenue down 41% at Rs 540.0 cr YoY 

*Ramco Systems:* Net loss at Rs 145.8 cr vs Rs 46.8 cr, Revenue down 9.1% at Rs 126.8 cr vs Rs 139.5 cr (YoY) 

*Siyaram Silk:* Net profit of Rs 61.0 cr vs profit of Rs 80.0 cr, Revenue down at Rs 586.0 cr vs Rs 636.0 cr YoY

Power Grid Corp:

The company acquired Beawar Dausa Transmission via tariff-based competitive bidding for an aggregate value of nearly Rs 21.37 crore, subject to adjustment.

Natco Pharma

Natco Pharma’s consolidated net profit increased 31 per cent to Rs. 420 crore in the first quarter ended June 30, 2023 against Rs. 320 crore in the corresponding quarter of the previous financial year I want to say we’ll go past Rs. 1,000 crore. But how much more than Rs. 1,000 crore, depends on how the market plays out. So that’s a little difficult to guess. I think Rs. 1,000 crore to Rs 1,200 crore range is my expectation,’‘ he said in the first quarter earnings call. The Hyderabad-based company is also expecting its newly-started agro chemicals division to register further growth this year. It is targeting a revenue of Rs. 50 crore to Rs. 200 crore in the current financial year. “The season just started. I would say we have gone from Rs. 1 crore s to Rs. 45 crore. It’s a fairly good run.’‘ Nannapaneni said. Natco is currently running promotional advertisements in Telangana for its agri products and also plans to take up a similar campaign in Maharashtra soon. We are filing our agro portfolio outside India. So the export business might take two to three years from now. But overall, I think my expectation is that the business should grow to around Rs. 400 crore to Rs. 500 crore in the next three to four years. And it will be a good solid business and contributing solidly for our both bottom line and top line,’‘ the CEO said. Natco is also witnessing organic business growth in Chlorantraniliprole (CTPR) in the domestic market is doing registration outside India as well. It had already filed the product in Brazil. Natco Pharma’s consolidated net profit increased 31 per cent to Rs. 420 crore in the first quarter ended June 30, 2023 against Rs. 320 crore in the corresponding quarter of the previous financial year on 26.3 per cent growth in total revenue at Rs. 1,160 crore. Major drivers of business during the quarter were from formulation exports, strong growth in domestic business of both pharma and agro, and steady sales from subsidiaries.